PRCT vs. NVO
Compare and contrast key facts about PROCEPT BioRobotics Corporation (PRCT) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PRCT or NVO.
Correlation
The correlation between PRCT and NVO is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PRCT vs. NVO - Performance Comparison
Key characteristics
PRCT:
1.63
NVO:
-0.43
PRCT:
3.05
NVO:
-0.37
PRCT:
1.35
NVO:
0.95
PRCT:
4.82
NVO:
-0.36
PRCT:
13.01
NVO:
-1.15
PRCT:
7.91%
NVO:
13.25%
PRCT:
63.21%
NVO:
35.35%
PRCT:
-63.51%
NVO:
-71.30%
PRCT:
-18.38%
NVO:
-41.92%
Fundamentals
PRCT:
$4.79B
NVO:
$486.49B
PRCT:
-$1.95
NVO:
$2.99
PRCT:
$199.84M
NVO:
$270.58B
PRCT:
$112.10M
NVO:
$229.07B
PRCT:
-$90.62M
NVO:
$135.97B
Returns By Period
In the year-to-date period, PRCT achieves a 93.68% return, which is significantly higher than NVO's -16.93% return.
PRCT
93.68%
-12.44%
35.46%
90.76%
N/A
N/A
NVO
-16.93%
-19.26%
-39.90%
-16.95%
26.03%
17.16%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PRCT vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for PROCEPT BioRobotics Corporation (PRCT) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PRCT vs. NVO - Dividend Comparison
PRCT has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.70%.
TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
PROCEPT BioRobotics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Novo Nordisk A/S | 1.70% | 0.99% | 1.18% | 1.34% | 1.86% | 2.12% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% | 1.72% |
Drawdowns
PRCT vs. NVO - Drawdown Comparison
The maximum PRCT drawdown since its inception was -63.51%, smaller than the maximum NVO drawdown of -71.30%. Use the drawdown chart below to compare losses from any high point for PRCT and NVO. For additional features, visit the drawdowns tool.
Volatility
PRCT vs. NVO - Volatility Comparison
The current volatility for PROCEPT BioRobotics Corporation (PRCT) is 12.25%, while Novo Nordisk A/S (NVO) has a volatility of 20.84%. This indicates that PRCT experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PRCT vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between PROCEPT BioRobotics Corporation and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities